What we do
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Opiate addiction withdrawal syndrome
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.
Cannabidiol in patients with treatment-resistant epilepsy:
an open-label interventional trial
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial